Symbol="CMRX"
AssetType="Common Stock"
Name="Chimerix Inc"
Description="Chimerix, Inc., a developing-stage biopharmaceutical company, focuses on accelerating the advancement of various drugs that impact the lives of patients living with cancer and other serious diseases. The company is headquartered in Durham, North Carolina."
CIK="1117480"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2505 MERIDIAN PARKWAY, SUITE 100, DURHAM, NC, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="106300000"
EBITDA="-56029000"
PERatio="0.597"
PEGRatio="0"
BookValue="2.713"
DividendPerShare="0"
DividendYield="0"
EPS="2.01"
RevenuePerShareTTM="0.388"
ProfitMargin="5.15"
OperatingMarginTTM="-1.646"
ReturnOnAssetsTTM="-0.216"
ReturnOnEquityTTM="1.219"
RevenueTTM="34092000"
GrossProfitTTM="-36486000"
DilutedEPSTTM="2.01"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="17.87"
AnalystTargetPrice="7.29"
TrailingPE="0.597"
ForwardPE="1.214"
PriceToSalesRatioTTM="5.27"
PriceToBookRatio="0.627"
EVToRevenue="3.575"
EVToEBITDA="1.457"
Beta="1.101"
num_52WeekHigh="2.9"
num_52WeekLow="1.09"
num_50DayMovingAverage="1.287"
num_200DayMovingAverage="1.589"
SharesOutstanding="88584000"
DividendDate="None"
ExDividendDate="None"
symbol="CMRX"
open="1.20"
high="1.22"
low="1.18"
price="1.20"
volume="558624.00"
latest_trading_day="2023-07-21"
previous_close="1.19"
change="0.01"
change_percent="0.8403%"
aroon_positive_momentum_days="32"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="32"
Volume_recent_avg="1021651"
Change_recent_avg="-0.01"
Delta_recent_avg="0.06"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-0.74"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="32"
Aroon_momentum_negative="68"
image_negative_thumbnail_id_1="144"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0032.jpeg"
image_negative_thumbnail_id_2="140"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0036.jpeg"
image_neutral_thumbnail_id_1="527"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_neutral_thumbnail_id_2="551"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0048.jpeg"
image_positive_thumbnail_id_1="1006"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0168.jpeg"
image_positive_thumbnail_id_2="650"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0058.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
